Nelson: Optimistic about innovation possibly impacting cancer

12:15 PM ET Thu, 1 Dec 2016

CNBC's Meg Tirrell speaks to Robert Nelsen, ARCH Venture Partners founder, about Trump's potential impact on the drug industry, and the future of biotech.